
CI
The Cigna Group
Company Overview
| Mkt Cap | $80.55B | Price | $271.54 |
| Volume | 1.89M | Change | -0.94% |
| P/E Ratio | 23.5 | Open | $272.09 |
| Revenue | $244.4B | Prev Close | $274.11 |
| Net Income | $3.4B | 52W Range | $239.51 - $350.00 |
| Div Yield | 6.04% | Target | $330.23 |
| Overall | 61 | Value | 100 |
| Quality | 55 | Technical | 30 |
No chart data available
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest News
Gryphon Capital Income Trust Reports NTA of $2.0098 per Unit
SMCI Stock Braces for Q2 Earnings – Analysts Cautious, Options Eye 12% Swing
Courage Investment Keeps Authorised Share Capital Unchanged in January 2026
CITIC Securities Delivers Strong 2025 Growth as It Accelerates First-Class Investment Bank Strategy
Archean Chemical Schedules Q3 and Nine-Month FY26 Earnings Call for 6 February
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CI | $271.54 | -0.9% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |